Acceptability Dermacyd Wipes - Lactoserum - Hygiene

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up of Dermacyd Wipes

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00397527

Enrollment

Registered

2006-11-09

Start date

2006-07-31

Completion date

Unknown

Last updated

2008-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Wipes

Interventions

DRUGlactoserum

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional. Main criteria are listed hereafter: Inclusion Criteria: * Integral skin in the tested region

Exclusion criteria

* Pregnancy or breastfeeding women; * Use of antiinflammatory or immunosuppression drugs; * Topical medication use at the region to be treated; * Cutaneous disease or active gynaecological disease which may interfer in study results; * Personal history of allergic disease at the area to be treated; * Allergic or atopic history.

Design outcomes

Primary

Measure	Time frame
Adverse events and their association with the treatment.	—

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026